Real-world treatment patterns and outcomes with olutasidenib after venetoclax in <i>IDH1</i> -mutated AML using EHR data.Yasmin Abaza, Catherine Lai, Jorge E. Cortes et al.|Journal of Clinical Oncology|2026Cited by 0